Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 181
Filtrer
1.
J Foot Ankle Surg ; 58(4): 785-791, 2019 Jul.
Article de Anglais | MEDLINE | ID: mdl-31010769

RÉSUMÉ

Subtalar joint distraction arthrodesis has been recommended for the treatment of conditions such as nonunion or malunion of subtalar joint arthrodesis posttraumatic arthritis. Both conditions are difficult to treat, because the deformities created in the frontal and sagittal planes of these conditions are complex. If these malalignments are not addressed, ankle joint instability and wear occur over time. In general, either autograft or allograft bone has been used to perform distraction arthrodesis of the subtalar joint. Although studies have shown successful use, there have been complications. Autografts have resulted in donor site morbidity and limitations on graft size, and allografts have shown high nonunion rates. Both autografts and allografts have shown graft collapse over time. Recent literature has discussed the use of tantalum technology to span large defects in bone healing. Studies have shown that tantalum provides superior strength and bone incorporation compared with autografts and allografts. This case series presents 2 cases in which tantalum truss technology was used for distraction arthrodesis. Although this series is limited in patient numbers, both cases show effective graft incorporation with no loss in height over time and earlier return to activity compared with previous studies that used autograft and allograft wedges.


Sujet(s)
Arthrite/chirurgie , Arthrodèse/méthodes , Calcanéus/traumatismes , Cals vicieux/chirurgie , Articulation subtalaire/chirurgie , Cheville/imagerie diagnostique , Arthrite/étiologie , Calcanéus/imagerie diagnostique , Femelle , Fractures osseuses/complications , Humains , Mâle , Adulte d'âge moyen , Ostéogenèse par distraction , Complications postopératoires/chirurgie , Radiographie , Amplitude articulaire , Articulation subtalaire/imagerie diagnostique , Titane , Tomodensitométrie
2.
Health Educ Res ; 32(3): 269-278, 2017 06 01.
Article de Anglais | MEDLINE | ID: mdl-28482058

RÉSUMÉ

Despite substantial research into underage youth's source of alcohol, few studies have examined how they go about obtaining alcohol through various means. This study explored the nature of alcohol access by Chinese adolescents and how their own perceptions around alcohol availability influence them to source alcohol in particular ways. This research involved focus groups with 111 young people aged 14-17 in Hong Kong, China. A grounded theory analysis was conducted using NVivo 10. While participants perceived ease of obtaining alcohol from retail outlets, proxy purchasing through friendship group members was reported as routine experience primarily to avoid potential embarrassment of being turned away. Convincing vendors that they were of legal drinking age was the convention used most commonly by Chinese teen drinkers. Participants expressed resentment toward adults who were willing to supply minors with alcohol. Nevertheless, this feeling of disappointment did not alter the ways they sourced alcohol. Access activities embodied a symbol of group identity in the collectivist Chinese culture. Results suggest that greater consideration should be given to understanding the complex interplay between alcohol access and community experience within peers. The perceived importance of face saving in Chinese culture may provide avenues for preventing youth access to alcohol.


Sujet(s)
Asiatiques , Commerce , Groupe de pairs , Étudiants/statistiques et données numériques , Consommation d'alcool par les mineurs/prévention et contrôle , Adolescent , Chine , Femelle , Groupes de discussion , Théorie ancrée , Humains , Mâle , Recherche qualitative , Enquêtes et questionnaires , Consommation d'alcool par les mineurs/psychologie
3.
Clin Oncol (R Coll Radiol) ; 29(4): 263-273, 2017 04.
Article de Anglais | MEDLINE | ID: mdl-28057404

RÉSUMÉ

AIMS: A normal tissue complication probability (NTCP) model of severe acute mucositis would be highly useful to guide clinical decision making and inform radiotherapy planning. We aimed to improve upon our previous model by using a novel oral mucosal surface organ at risk (OAR) in place of an oral cavity OAR. MATERIALS AND METHODS: Predictive models of severe acute mucositis were generated using radiotherapy dose to the oral cavity OAR or mucosal surface OAR and clinical data. Penalised logistic regression and random forest classification (RFC) models were generated for both OARs and compared. Internal validation was carried out with 100-iteration stratified shuffle split cross-validation, using multiple metrics to assess different aspects of model performance. Associations between treatment covariates and severe mucositis were explored using RFC feature importance. RESULTS: Penalised logistic regression and RFC models using the oral cavity OAR performed at least as well as the models using mucosal surface OAR. Associations between dose metrics and severe mucositis were similar between the mucosal surface and oral cavity models. The volumes of oral cavity or mucosal surface receiving intermediate and high doses were most strongly associated with severe mucositis. CONCLUSIONS: The simpler oral cavity OAR should be preferred over the mucosal surface OAR for NTCP modelling of severe mucositis. We recommend minimising the volume of mucosa receiving intermediate and high doses, where possible.


Sujet(s)
Tumeurs de la tête et du cou/radiothérapie , Muqueuse de la bouche/effets des radiations , Inflammation muqueuse/étiologie , Radiothérapie/effets indésirables , Adolescent , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Humains , Modèles logistiques , Adulte d'âge moyen , Modèles biologiques , Probabilité , Radiothérapie/méthodes , Dosimétrie en radiothérapie , Reproductibilité des résultats , Jeune adulte
4.
Biomed Pharmacother ; 61(9): 520-6, 2007 Oct.
Article de Anglais | MEDLINE | ID: mdl-17913445

RÉSUMÉ

Epstein--Barr virus latent infection is associated with human malignancies including Burkitt's lymphoma, gastric carcinoma and the highly invasive nasopharyngeal carcinoma (NPC). Increased expression of EBV latent membrane protein 1, LMP1, is correlated with tumor progression and metastasis in NPC. LMP1 induces cellular proteins including cytokines and matrix metalloproteinases (e.g., MMP1, MMP2 and MMP9). MMPs are endopeptidases involved in the degradation of extracellular matrix proteins; and their upregulation in cancer implicates their potential role in tumor metastasis. In light of the role of LMP1 in cytokine dysregulation and the fact that MMPs are regulated by cytokines, we examined whether LMP1 promotes NPC metastasis via the induction of MMPs. To delineate the oncogenic role of LMP1 in NPC, we first investigated the induction of MMP1, MMP2, MMP3 and MMP9 in LMP1-positive NPC tumor samples (n=15) by quantitative RT-PCR. We showed a significant induction of MMP1 and MMP3 transcripts in the EBV LMP1-positive NPC tissues, compared with biopsies obtained from the adjacent non-tumor tissues. To investigate the role of LMP1 in MMP expression in NPC, we cloned the LMP1 gene from NPC samples and transiently expressed it in MRC5 cells (human lung fibroblasts). Following transfection, a time-dependent elevation of endogenous MMP3 expression was found in the LMP1-transfectants by quantitative RT-PCR and Western analysis. Taken together, we observed that MMP3 is upregulated in LMP1-positive NPC tumors and LMP1-expression in fibroblasts is associated with MMP3 and cytokine expression. Our results suggest that LMP1 may contribute to invasiveness of NPC cells via the expression of MMP3 in fibroblasts.


Sujet(s)
Carcinomes/métabolisme , Matrix metalloproteinases/biosynthèse , Tumeurs du rhinopharynx/métabolisme , Protéines de la matrice virale/pharmacologie , Adulte , Sujet âgé , Technique de Western , Carcinomes/anatomopathologie , Cellules cultivées , Clonage moléculaire , Évolution de la maladie , Induction enzymatique/effets des médicaments et des substances chimiques , Femelle , Humains , Immunohistochimie , Mâle , Adulte d'âge moyen , Tumeurs du rhinopharynx/anatomopathologie , Invasion tumorale/anatomopathologie , Métastase tumorale/anatomopathologie , ARN/biosynthèse , ARN/génétique , RT-PCR , Transfection , Protéines de la matrice virale/génétique , Protéines de la matrice virale/isolement et purification
5.
Br J Cancer ; 96(4): 623-30, 2007 Feb 26.
Article de Anglais | MEDLINE | ID: mdl-17285127

RÉSUMÉ

We have monitored Epstein-Barr virus (EBV) IgA antibody levels of 39 nasopharyngeal carcinoma (NPC) cases for up to 15 years before clinical onset of NPC, and assessed preclinical serologic status of another 68 cases. Our results identify a serologic window preceding diagnosis when antibody levels are raised and sustained. This window can persist for as long as 10 years, with a mean duration estimated to as 37+/-28 months. Ninety-seven of these 107 NPC cases exhibited such a window. Cases that did not may reflect individual antibody response to EBV. Serologic screening at enrollment identified those cases who had already entered the window and became clinically manifested earlier (median=28 months) than those who entered the window after enrollment (median=90 months). The former account for 19 of 21 cases diagnosed within 2 years of screening. Nasopharyngeal carcinoma risk levels among seropositive subjects were also highest during this period. Both prediction rates and risk levels declined thereafter; cases detected at later times were composed of increasing proportions of individuals who entered the serological window after screening. Our findings establish EBV antibody as an early marker of NPC and suggest that repeated screening to monitor cases as they enter this window has considerable predictive value, with practical consequences for cancer treatment.


Sujet(s)
Anticorps antiviraux/sang , Herpèsvirus humain de type 4/immunologie , Immunoglobuline A/sang , Tumeurs du rhinopharynx/diagnostic , Tumeurs du rhinopharynx/immunologie , Adulte , Évolution de la maladie , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Tumeurs du rhinopharynx/sang , Stadification tumorale , Valeur prédictive des tests , Facteurs de risque , Sensibilité et spécificité , Tests sérologiques/méthodes
6.
Dis Esophagus ; 19(6): 459-67, 2006.
Article de Anglais | MEDLINE | ID: mdl-17069589

RÉSUMÉ

Esophageal squamous cell carcinoma (SCC) remains the leading cause of cancer related deaths in Linzhou (formerly Linxian), the highest incidence area for esophageal cancer (EC) in Henan, northern China. In China, gastric cardia adenocarcinoma (GCA) shares very similar geographic distribution with SCC, suggesting the possibility of similar risk factors involved in SCC and GCA carcinogenesis in these areas. However, the underlying genetic alterations for esophageal and gastric cardia carcinogenesis, especially for the molecular difference between SCC and GCA, are largely unknown. The present study was thus undertaken to determine the difference in chromosomal aberrations in SCC (n = 37) and GCA (n = 31) using the comparative genomic hybridization method (CGH). All the patients were from Linzhou, Henan, a high-risk geographic region for both SCC and GCA. CGH results showed that chromosomal aberrations with different degrees were identified both in SCC and GCA. In SCC, chromosomal profile of DNA copy number was characterized by most frequently detected gains at 8q (29/37, 78%), 3q (24/37, 65%) and 5p (19/37, 51%); and frequently detected losses at 3p (21/37, 57%), 8p and 9q (14/37, 38%). In GCA, the frequently detected gains were identified at 20q (13/31, 42%), 6q (12/31, 39%) and 8q (11/31, 35%); the DNA copy number losses in GCA occurred frequently at 17p (17/31, 55%), 19p (15/31, 48%) and 1p (14/31, 45%). Statistically, there were evident differences between SCC and GCA in DNA copy number gains at 8q, 3q, 5p and 20q (P < 0.05) and in losses at 3p, 8p, 5q, 17p and 18q (P < 0.05). Gains at 8q were frequently observed in both SCC and GCA. Gains at 3q and 8p were frequently observed in TNM stage III of both SCC and GCA. The present CGH results provide candidate regions that may contain specific related genes involved in SCC and GCA in the Linzhou population. Gains at 8q, 3q and 5p and losses at 3p, 8p and 9q were specifically implicated in SCC; gains at 20q, 6q and 8q and losses at 17p, 19p and 1p were specifically implicated in GCA; gains at 8q were implicated in both SCC and GCA.


Sujet(s)
Adénocarcinome/génétique , Carcinome épidermoïde/génétique , Aberrations des chromosomes , Tumeurs de l'oesophage/génétique , Adénocarcinome/épidémiologie , Carcinome épidermoïde/épidémiologie , Carcinome épidermoïde/anatomopathologie , Cardia , Chine/épidémiologie , Tumeurs de l'oesophage/épidémiologie , Tumeurs de l'oesophage/anatomopathologie , Dosage génique/génétique , Analyse de profil d'expression de gènes , Humains , Incidence , Stadification tumorale
7.
Br J Cancer ; 94(1): 108-14, 2006 Jan 16.
Article de Anglais | MEDLINE | ID: mdl-16404364

RÉSUMÉ

Clinically, human glioblastoma (GBM) may develop de novo or from a low-grade glioma (secondary GBM), and molecular alterations in the two pathways may differ. This study examined the status of Survivin expression and apoptosis in 30 primary and 26 secondary GBMs. Our results show that cytoplasmic Survivin positivity was significantly (P<0.001) more frequent in primary GBMs (83%) than that in secondary GBMs (46%). In addition, an inverse correlation of cytoplasmc Survivin positivity with GBM apoptotic index, and a positive association between cytoplasmic Survivin and size of the tumours were observed. These results suggest that cytoplasmic Survivin, via its antiapoptotic function, may be involved in the tumorigenesis of many primary GBMs, but only in a small fraction of secondary GBMs. Furthermore, the overall progression times from low-grade precursor lesions to secondary GBMs were significantly shorter (P<0.05) in cytoplasmic Survivin-positive cases (mean, 15.6 months) than those in Survivin-negative cases (mean, 23.8 moths), and the positive expression level of Survivin in cytoplasm was upregulated in most secondary GBMs when compared to matched pre-existing low-graded lesions. These results suggest that the increased accumulation of Survivin in the cytoplasm of more malignant glioma cells may prove to be a selective advantage, thus accelerating progression to a more aggressive phenotype.


Sujet(s)
Apoptose , Tumeurs du cerveau/génétique , Tumeurs du cerveau/physiopathologie , Glioblastome/génétique , Glioblastome/physiopathologie , Protéines associées aux microtubules/biosynthèse , Protéines tumorales/biosynthèse , Adolescent , Adulte , Sujet âgé , Tumeurs du cerveau/secondaire , Transformation cellulaire néoplasique , Enfant , Évolution de la maladie , Femelle , Analyse de profil d'expression de gènes , Glioblastome/secondaire , Humains , Immunohistochimie , Protéines IAP , Mâle , Adulte d'âge moyen , Phénotype , Pronostic , Survivine
8.
Oncogene ; 25(8): 1242-50, 2006 Feb 23.
Article de Anglais | MEDLINE | ID: mdl-16247463

RÉSUMÉ

To identify genes associated with tumor metastasis in hepatocellular carcinoma (HCC), gene expression profiles between a pair of primary HCC (H2-P) and their matched metastatic HCC (H2-M) were compared. Overexpression of clusterin (CLU) was found in H2-M cells. To determine the roles CLU played in HCC metastasis, CLU was transfected into H2-P cells. Overexpression of CLU in H2-P cells increased cell migration by twofold in vitro and formation of metastatic tumor nodules in liver by eightfold in vivo. To evaluate the correlation of CLU expression with HCC metastasis, the expression levels of CLU in HCCs were investigated using a tissue microarray (TMA) containing 104 pairs of primary HCCs and their matched metastases. The frequency of CLU overexpression increased significantly in metastatic HCCs (59.1%) compared with that in primary tumors (32.6%, P<0.001). To gain additional insight into the function of CLU, the expression profile of H2P-CLU was compared with vector-transfected H2-P cells by cDNA microarray. A total of 35 upregulated and 14 downregulated genes were detected in H2P-CLU. One of the upregulated genes known as YKL-40, which is implicated in matrix-remodeling and metastasis, was further studied using TMA. A significant correlation (P<0.001) between the expression levels of YKL-40 and CLU was observed, implying that the CLU-YKL-40 pathway may play an important role in HCC metastasis.


Sujet(s)
Carcinome hépatocellulaire/secondaire , Clusterine/métabolisme , Tumeurs expérimentales du foie , Adipokines , Animaux , Marqueurs biologiques tumoraux , Tumeurs osseuses/métabolisme , Tumeurs osseuses/secondaire , Carcinome hépatocellulaire/métabolisme , Mouvement cellulaire , Protéine-1 similaire à la chitinase-3 , Femelle , Analyse de profil d'expression de gènes , Glycoprotéines/métabolisme , Humains , Tumeurs du rein/métabolisme , Tumeurs du rein/secondaire , Lectines , Tumeurs expérimentales du foie/métabolisme , Tumeurs expérimentales du foie/anatomopathologie , Métastase lymphatique/anatomopathologie , Souris , Souris SCID , Séquençage par oligonucléotides en batterie , Analyse sur puce à tissus
9.
Eur J Surg Oncol ; 31(5): 555-8, 2005 Jun.
Article de Anglais | MEDLINE | ID: mdl-15922893

RÉSUMÉ

AIMS: We evaluated the clinicopathologic relevance of plasma osteopontin (OPN) level in nasopharyngeal carcinoma patients. METHODS: Seventy-two plasma samples were collected from patients with undifferentiated nasopharyngeal carcinoma (NPC) before radiotherapy. Plasma OPN level was determined by quantitative sandwich enzyme immunoassay. The plasma OPN level was evaluated for its clinicopathologic relevance. RESULTS: The mean plasma OPN level was significantly higher in NPC patients than in normal controls (184.66 vs 75.89 ng/ml, p<0.001). In addition, high OPN level was found in the patients with advanced cancer and was correlated with neck node metastasis (p<0.05). CONCLUSIONS: Our findings indicated a potential role of OPN in the pathogenesis and nodal metastasis of undifferentiated NPC.


Sujet(s)
Tumeurs du rhinopharynx/sang , Sialoglycoprotéines/sang , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Marqueurs biologiques tumoraux/sang , Femelle , Humains , Mâle , Adulte d'âge moyen , Tumeurs du rhinopharynx/anatomopathologie , Stadification tumorale , Ostéopontine
10.
J Cancer Res Clin Oncol ; 130(10): 591-603, 2004 Oct.
Article de Anglais | MEDLINE | ID: mdl-15243805

RÉSUMÉ

PURPOSE: Telomerase reverse transcriptase (hTERT) is the key determinant of telomerase activity and plays a crucial role in cellular immortalization and oncogenesis. It will be a promising target for cancer gene therapy. We constructed a novel replicative adenovirus CNHK300 in which hTERT promoter with three extra E-boxes downstream of the promoter was introduced and used to regulate adenoviral E1a gene, and studied its properties of selective replication in cancer cells and antitumoral activity. METHODS: Luciferase assay was used to detect hTERT promoter activity. The selective replication of CNHK300 in cancer cells was investigated by E1a Western blot and green fluorescent protein (GFP) reporter gene assay. The antitumoral activity of CNHK300 and its toxicity were measured on animal models. RESULTS: Luciferase assay showed that introducing extra E-boxes downstream of hTERT promoter is beneficial to decreasing the promoter activity in normal cells without affecting its strong activity in cancer cells. Experiments in vitro and in vivo demonstrated that CNHK300 can selectively target to hTERT-positive cancer cells and replicate in them, resulting in oncolytic or antitumoral effect. CNHK300 is superior to ONYX-015 in terms of selective replication and oncolytic or antitumoral effect. The toxicity assay showed no signs of toxicity to liver cells even at the higher dosage of CNHK300 in vivo. CONCLUSION: The hTERT promoter-controlled, replication-competent adenovirus CNHK300 is a promising system for targeted cancer gene therapy.


Sujet(s)
Adenoviridae/génétique , Tumeurs/enzymologie , Telomerase/génétique , Animaux , Protéines de liaison à l'ADN , Thérapie génétique/méthodes , Protéines à fluorescence verte , Humains , Souris , Souris nude , Transplantation tumorale , Tumeurs/virologie , Régions promotrices (génétique) , RT-PCR , Telomerase/métabolisme
11.
Br J Radiol ; 77(919): 568-72, 2004 Jul.
Article de Anglais | MEDLINE | ID: mdl-15238403

RÉSUMÉ

The aim of this study is to demonstrate the use of inverse planning in three-dimensional conformal radiation therapy (3DCRT) of oesophageal cancer patients and to evaluate its dosimetric results by comparing them with forward planning of 3DCRT and inverse planning of intensity-modulated radiotherapy (IMRT). For each of the 15 oesophageal cancer patients in this study, the forward 3DCRT, inverse 3DCRT and inverse IMRT plans were produced using the FOCUS treatment planning system. The dosimetric results and the planner's time associated with each of the treatment plans were recorded for comparison. The inverse 3DCRT plans showed similar dosimetric results to the forward plans in the planning target volume (PTV) and organs at risk (OARs). However, they were inferior to that of the IMRT plans in terms of tumour control probability and target dose conformity. Furthermore, the inverse 3DCRT plans were less effective in reducing the percentage lung volume receiving a dose below 25 Gy when compared with the IMRT plans. The inverse 3DCRT plans delivered a similar heart dose as in the forward plans, but higher dose than the IMRT plans. The inverse 3DCRT plans significantly reduced the operator's time by 2.5 fold relative to the forward plans. In conclusion, inverse planning for 3DCRT is a reasonable alternative to the forward planning for oesophageal cancer patients with reduction of the operator's time. However, IMRT has the better potential to allow further dose escalation and improvement of tumour control.


Sujet(s)
Tumeurs de l'oesophage/radiothérapie , Planification de radiothérapie assistée par ordinateur/méthodes , Radiothérapie conformationnelle/méthodes , Tumeurs de l'oesophage/anatomopathologie , Coeur/effets des radiations , Humains , Poumon/effets des radiations , Dose de rayonnement , Radiométrie/méthodes , Dosimétrie en radiothérapie , Moelle spinale/effets des radiations , Facteurs temps
12.
Eur J Surg Oncol ; 30(5): 560-4, 2004 Jun.
Article de Anglais | MEDLINE | ID: mdl-15135487

RÉSUMÉ

UNLABELLED: Increased in plasma pro-MMP2 and pro-MMP9 levels in patients with advanced stage NPC were observed. Plasma pro-MMP2 is a significant independent prognostic marker for undifferentiated NPC. AIM: Upregulation of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) expression is observed in many cancers and high level of these proteins are found in peripheral blood of many cancer patients. In this study, we aimed at evaluating the plasma pro-MMP2 and pro-MMP9 pro-enzymes (pro-MMP2 and pro-MMP9) levels and their clinical significances in patients with undifferentiated nasopharyngeal carcinoma (NPC). METHODS: The plasma pro-MMP2 and pro-MMP9 levels were measured in 40 NPC patients and 40 normal individuals by enzyme linked immunosorbant assay. RESULTS: By using the Cox-regression model, a high pro-MMP2 level was found to be significantly correlated with poorer survival. Patients with plasma pro-MMP2 below 650 ng/ml had higher 5-year survival rate of 89%, compared with 50% for patients with plasma pro-MMP2 above 650 ng/ml. CONCLUSIONS: A high level of plasma pro-MMP2 was associated with poor survival of NPC patients independent of sex, age and stage.


Sujet(s)
Marqueurs biologiques tumoraux/sang , Carcinomes/sang , Carcinomes/anatomopathologie , Matrix metalloproteinase 2/sang , Matrix metalloproteinase 9/sang , Tumeurs du rhinopharynx/sang , Tumeurs du rhinopharynx/anatomopathologie , Adulte , Facteurs âges , Carcinomes/mortalité , Chine , Femelle , Études de suivi , Humains , Mâle , Adulte d'âge moyen , Analyse multifactorielle , Tumeurs du rhinopharynx/mortalité , Stadification tumorale , Facteurs sexuels , Analyse de survie , Facteurs temps
13.
Respir Med ; 97(6): 618-24, 2003 Jun.
Article de Anglais | MEDLINE | ID: mdl-12814145

RÉSUMÉ

BACKGROUND: Non-small cell lung cancer (NSCLC) is a leading cause of cancer deaths, and over 60% of patients present with advanced stages. Although polysaccharide peptides (PSP), isolated from the fungus Coriolus versicolor, have been reported to have anti-tumor effects, its clinical efficacy has not been properly evaluated. METHODS: Double-blind placebo-controlled randomized study to evaluate the effects of 28-day administration of PSP (Windsor Pharmaceutical, Hong Kong) on patients, who had completed conventional treatment for advanced NSCLC. RESULTS: Thirty-four patients, with no significant difference in their baseline demographic, clinical or tumor characteristics, or previous treatment regimes (P>0.05) were recruited into each of the PSP and control arms. After 28-day treatment, there was a significant improvement in blood leukocyte and neutrophil counts, serum IgG and IgM, and percent of body fat among the PSP, but not the control, patients (P<0.05). Although the evaluable PSP patients did not improve in NSCLC-related symptoms, there were significantly less PSP patients withdrawn due to disease progression, than their control counterparts (5.9 and 23.5%, respectively; P=0.04; OR 4.00). There was no reported adverse reaction attributable to the trial medications. CONCLUSION: PSP treatment appears to be associated with slower deterioration in patients with advanced NSCLC.


Sujet(s)
Antinéoplasiques/usage thérapeutique , Carcinome pulmonaire non à petites cellules/traitement médicamenteux , Tumeurs du poumon/traitement médicamenteux , Protéoglycanes/usage thérapeutique , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Évolution de la maladie , Méthode en double aveugle , Femelle , Humains , Mâle , Adulte d'âge moyen , Projets pilotes
14.
Am J Physiol Lung Cell Mol Physiol ; 285(2): L322-33, 2003 Aug.
Article de Anglais | MEDLINE | ID: mdl-12665465

RÉSUMÉ

To determine whether reactive oxygen species (ROS) play an essential role in hypoxic pulmonary vasoconstriction (HPV) and the cellular locus of ROS production and action during HPV, we measured internal diameter (ID) at constant transmural pressure, lucigenin-derived chemiluminescence (LDCL), and electron paramagnetic resonance (EPR) spin adduct spectra in small distal porcine pulmonary arteries, and dichlorofluorescein (DCF) fluorescence in myocytes isolated from these arteries. Hypoxia (4% O2) decreased ID, increased DCF fluorescence, tended to increase LDCL, and in some preparations produced EPR spectra consistent with hydroxyl and alkyl radicals. Superoxide dismutase (SOD, 150 U/ml) or SOD + catalase (CAT, 200 U/ml) did not alter ID during normoxia but reduced or abolished the constriction induced by hypoxia. SOD also blocked HPV in endothelium-denuded arteries after restoration of the response by exposure to 10-10 M endothelin-1. Confocal fluorescence microscopy demonstrated that labeled SOD and CAT entered pulmonary arterial myocytes. SOD, SOD + CAT, and CAT blocked the increase in DCF fluorescence induced by hypoxia, but SOD + CAT and CAT also caused a stable increase in fluorescence during normoxia, suggesting that CAT diminished efflux of DCF from cells or oxidized the dye directly. We conclude that HPV required increased concentrations of ROS produced by and acting on pulmonary arterial smooth muscle rather than endothelium.


Sujet(s)
Catalase/pharmacologie , Hypoxie/physiopathologie , Muscles lisses vasculaires/physiopathologie , Artère pulmonaire/physiopathologie , Superoxide dismutase/pharmacologie , Vasoconstriction/physiologie , Acétylcholine/pharmacologie , Animaux , Spectroscopie de résonance de spin électronique , Hypoxie/anatomopathologie , Techniques in vitro , Cinétique , Mâle , Microscopie confocale , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Muscles lisses vasculaires/anatomopathologie , Artère pulmonaire/effets des médicaments et des substances chimiques , Artère pulmonaire/anatomopathologie , Suidae
15.
Br J Pharmacol ; 137(6): 739-48, 2002 Nov.
Article de Anglais | MEDLINE | ID: mdl-12411403

RÉSUMÉ

1. The effects of pharmacological preconditioning with U50488H (U(50)), a selective kappa-opioid receptor agonist, on Ca(2+) homeostasis in rat ventricular myocytes subjected for 9 min to metabolic inhibition (MI) and anoxia (A), consequences of ischaemia, were studied and compared with those of preconditioning with brief periods of MI/A. 2. Precondition with 30 micro M of U(50) for three cycles of 1 min each cycle separated by 3 min of recovery (UP) significantly increased the percentage of non-blue cells following MI/A. The effect of UP is the same as that of preconditioning with an inhibitor of glycolysis and an oxygen scavenger for three 1-min cycles separated by three-minute recovery (MI/AP). The results indicate that like MI/AP, UP also confers cardioprotection. 3. MI/A increased intracellular Ca(2+) ([Ca(2+)](i)) and reduced the amplitude of caffeine-induced [Ca(2+)](i) transients, an indication of Ca(2+) content in the sarcoplasmic reticulum (SR). MI/A also reduced the electrically-induced [Ca(2+)](i) transient, that indicates Ca(2+)-release during excitation-contraction coupling, and Ca(2+) sparks in unstimulated myocytes, that indicates spontaneous Ca(2+)-release from SR. It also prolonged the decline of the electrically-induced [Ca(2+)](i) transient and slowed down the recovery of the electrically-induced [Ca(2+)](i) transient after administration of caffeine. In addition, MI/A prolonged the decline of caffeine induced [Ca(2+)](i) transient, an indication of Na(+)-Ca(2+) exchange activity, and UP prevented it. So UP, that confers cardioprotection, prevented the changes induced by MI/A. With the exception of Ca(2+)-spark, which was not studied, the effects of MI/AP are the same as those of UP. 4. It is concluded that pharmacological preconditioning with U(50), that confers immediate cardioprotection, prevents changes of Ca(2+) homeostasis altered by MI/A in the rat heart. This may be responsible, at least partly, for the cardioprotective action. 5. The study also provided evidence that MI/A causes mobilization of Ca(2+) from SR to cytoplasm causing Ca(2+)-overload which may be due to reduced Ca(2+)-uptake by SR. MI/A also reduces spontaneous and electrically induced Ca(2+) release from SR.


Sujet(s)
2-(3,4-Dichlorophényl)-N-méthyl-N-((1S,2S)-2-(pyrrolidin-1-yl)cyclohexyl)acétamide/pharmacologie , Calcium/métabolisme , Myocytes cardiaques/effets des médicaments et des substances chimiques , Animaux , Caféine/pharmacologie , Hypoxie cellulaire/physiologie , Désoxyglucose/pharmacologie , Stimulation électrique , Ventricules cardiaques/cytologie , Ventricules cardiaques/effets des médicaments et des substances chimiques , Ventricules cardiaques/métabolisme , Homéostasie/effets des médicaments et des substances chimiques , Mâle , Myocytes cardiaques/cytologie , Myocytes cardiaques/métabolisme , Rats , Rat Sprague-Dawley , Récepteur kappa/agonistes , Facteurs temps
16.
J Pediatr Surg ; 37(5): 765-9, 2002 May.
Article de Anglais | MEDLINE | ID: mdl-11987096

RÉSUMÉ

BACKGROUND/PURPOSE: This study investigates the effect of epidermal growth factor (EGF) on nutrient absorption in a rat model of short bowel syndrome (SBS). METHODS: Male juvenile rats underwent either transection (Sham) or ileocecal resection leaving a 20-cm jejunal remnant. Animals underwent follow-up for 10 days, and resected animals were treated with placebo or recombinant human EGF (1-53). Animals were pair fed; in vivo nutrient absorption, intestinal permeability, morphology, and total intestinal DNA and protein content were measured. RESULTS: Resected EGF-treated animals lost significantly less weight than those in the placebo group (-4.2 +/- 3 v -13.7 +/- 6.9%), absorbed significantly more 3-0 methylglucose (76.8 +/- 6.6 v 64.9 +/- 10.1%), and had reduced permeability (lactulose/mannitol ratio, 0.35 +/- 0.19 v 0.60 +/- 0.20; P <.05 for all comparisons). CONCLUSIONS: These findings show that treatment of short bowel syndrome animals with EGF reduced weight loss and improved carbohydrate absorption and intestinal permeability. These findings suggest that enteral EGF may be a useful therapy for short bowel syndrome; further studies are indicated.


Sujet(s)
Facteur de croissance épidermique/usage thérapeutique , Syndrome de l'intestin court/traitement médicamenteux , Absorption , Animaux , Hydrates de carbone alimentaires/pharmacocinétique , Matières grasses alimentaires/pharmacocinétique , Protéines alimentaires/pharmacocinétique , Modèles animaux de maladie humaine , Mâle , Évaluation de l'état nutritionnel , Rats , Rat Sprague-Dawley , Syndrome de l'intestin court/métabolisme , Résultat thérapeutique , Prise de poids
17.
Arch Otolaryngol Head Neck Surg ; 127(12): 1457-62, 2001 Dec.
Article de Anglais | MEDLINE | ID: mdl-11735814

RÉSUMÉ

OBJECTIVES: To evaluate the efficacy of afterloading brachytherapy following radical neck dissection (RND) in the management of extensive cervical lymph node disease in nasopharyngeal carcinoma after radiotherapy; and to examine prospectively prognostic factors and the pathologic behavior of neck disease. PATIENTS: Twenty-seven patients with nasopharyngeal carcinoma who had extensive cervical lymph node metastasis following external radiotherapy were treated with RND. Thirteen of them also underwent afterloading brachytherapy with iridium wire (Ir 192). The RND specimens of the 27 patients were also examined with step serial whole-specimen sectioning. RESULTS: All patients survived and their wounds healed primarily. Pathologic examination revealed 183 tumor-bearing lymph nodes that contained tumors in the neck: level I, 4% (8/183); level II, 53% (96/183); level III, 34% (62/183); level IV, 5% (9/183); and level V, 4% (8/183). Extracapsular tumor extension was seen in 84% of patients. Multivariate analysis identified the number of tumor-bearing lymph nodes detected in the specimens to be the only significant factor that affected control of disease. Although the neck disease in the group of patients who had afterloading brachytherapy was more extensive, the 3-year actuarial tumor control for the groups with and without brachytherapy were 60% and 61%, respectively. CONCLUSIONS: Recurrent cervical lymph nodes after radiotherapy in nasopharyngeal carcinoma are extensive and RND is mandatory for a successful salvage. When the nodal metastasis infiltrate or adhere to surrounding tissue, afterloading brachytherapy with iridium wire can provide satisfactory local tumor control.


Sujet(s)
Curiethérapie , Carcinomes/thérapie , Tumeurs du rhinopharynx/thérapie , Adulte , Sujet âgé , Carcinomes/mortalité , Carcinomes/anatomopathologie , Carcinomes/radiothérapie , Association thérapeutique , Femelle , Humains , Radio-isotopes de l'iridium/usage thérapeutique , Métastase lymphatique , Mâle , Adulte d'âge moyen , Tumeurs du rhinopharynx/mortalité , Tumeurs du rhinopharynx/anatomopathologie , Tumeurs du rhinopharynx/radiothérapie , Cou , Évidement ganglionnaire cervical , Pronostic , Études prospectives , Taux de survie
18.
Cancer ; 92(11): 2845-55, 2001 Dec 01.
Article de Anglais | MEDLINE | ID: mdl-11753958

RÉSUMÉ

BACKGROUND: A retrospective analysis of treatment outcomes in patients with nasopharyngeal carcinoma (NPC) was performed in which the newly revised 1997 American Joint Committee on Cancer (AJCC) stage classification was applied and compared with the 1988 AJCC and Ho stage classifications, with emphasis on the predictive value of different staging systems in determining failure patterns in NPC. METHODS: Three hundred and twenty-four patients with newly diagnosed NPC treated between September 1989 and August 1991 and originally staged according to Ho stage classification were re-staged according to the 1988 and 1997 AJCC stage classifications. In addition to stage grouping, patients were also classified into the following prognostic categories to study the failure patterns: early disease group (T1-2N0-1), advanced local disease group (T3-4N0-1), advanced nodal disease group (T1-2N2-3), and advanced locoregional disease group (T3-4N2-3). The overall survival (OAS), relapse-free survival (RFS), local relapse-free survival, nodal relapse-free survival, and distant metastases-free survival were compared among different stage groups and prognostic categories in the three staging systems. RESULTS: In the new AJCC system, the percentages of patients with Stage I, II, III, and IV disease were 15.1%, 31.5%, 28.1%, and 25.3%, respectively, whereas most patients were classified as having Stage IV disease (65.7%) in the old AJCC system and Stage II or III disease (74.1%) in the Ho system. The 5 year OAS rates in the 1997 AJCC Stage I, II, III, and IV disease were 97.7%, 78.7%, 79.5%, and 61.4%, respectively. The corresponding 5 year RFS rates were 95.7%, 64.7%, 54.5%, and 41.1%. Using the 1997 AJCC system to define the four prognostic categories, the early disease group had the lowest incidence of relapse (27.6%) and death (18.4%), whereas the advanced locoregional disease group had the highest incidence of relapse (61.4%) and death (43.2%). Both the advanced local disease group and the advanced nodal disease group had similar rates of relapse (46.7% vs. 47.2%), but local relapse was the major cause of failure in the former group (61.8%), whereas distant metastases was the major cause in the latter group (44%). CONCLUSIONS: Using the 1997 AJCC staging system, the authors observed a better distribution of patient numbers as well as segregation of survival curves among different stage groups. Moreover, prognostic categories with distinct prognosis and failure patterns were definable by the new system, which has important implications in selecting appropriate patient treatment strategies.


Sujet(s)
Tumeurs du rhinopharynx/anatomopathologie , Stadification tumorale/classification , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Femelle , Humains , Mâle , Adulte d'âge moyen , Tumeurs du rhinopharynx/diagnostic , Tumeurs du rhinopharynx/mortalité , Valeur prédictive des tests , Pronostic , Analyse de survie
19.
Anticancer Res ; 21(4B): 3081-4, 2001.
Article de Anglais | MEDLINE | ID: mdl-11712814

RÉSUMÉ

BACKGROUND: Chinese nasopharyngeal carcinoma (NPC) specimens were analyzed by microsatellite allelotyping to evaluate their usefulness as biomarkers for cancer detection. MATERIALS AND METHODS: A panel of eight microsatellite markers localized to chromosomes 3p, 6p, 9p, I1q and 14q were used to study 47 specimens. RESULTS: A moderately low loss of heterozygosity (LOH) frequency (8% to 35%) was observed; 23 (49%) specimens showed LOH with at least one marker while microsatellite instability (MSI) was detected in 10 specimens (21%). CONCLUSION: Poor survival was significantly associated with LOH detected by a chromosome 3 marker. Interestingly, tumors with multiple genetic alterations were significanty associated with earlier staging


Sujet(s)
Allèles , Carcinomes/génétique , Chromosomes humains/génétique , Répétitions microsatellites , Tumeurs du rhinopharynx/génétique , Adulte , Sujet âgé , Carcinomes/mortalité , Chromosomes humains de la paire 11/génétique , Chromosomes humains de la paire 14/génétique , Chromosomes humains de la paire 3/génétique , Chromosomes humains de la paire 6/génétique , Chromosomes humains de la paire 9/génétique , Femelle , Hong Kong/épidémiologie , Humains , Perte d'hétérozygotie , Mâle , Adulte d'âge moyen , Tumeurs du rhinopharynx/mortalité , Pronostic , Analyse de survie
20.
Am J Physiol Lung Cell Mol Physiol ; 281(5): L1115-22, 2001 Nov.
Article de Anglais | MEDLINE | ID: mdl-11597902

RÉSUMÉ

Recent studies demonstrate that endothelin-1 (ET-1) constricts human pulmonary arteries (PA). In this study, we examined possible mechanisms by which ET-1 might constrict human PA. In smooth muscle cells freshly isolated from these arteries, whole cell patch-clamp techniques were used to examine voltage-gated K(+) (K(V)) currents. K(V) currents were isolated by addition of 100 nM charybdotoxin and were identified by current characteristics and inhibition by 4-aminopyridine (10 mM). ET-1 (10(-8) M) caused significant inhibition of K(V) current. Staurosporine (1 nM), a protein kinase C (PKC) inhibitor, abolished the effect of ET-1. Rings of human intrapulmonary arteries (0.8-2 mm OD) were suspended in tissue baths for isometric tension recording. ET-1-induced contraction was maximal at 10(-8) M, equal to that induced by K(V) channel inhibition with 4-aminopyridine, and attenuated by PKC inhibitors. These data suggest that ET-1 constricts human PA, possibly because of myocyte depolarization via PKC-dependent inhibition of K(V). Our results are consistent with data we reported previously in the rat, suggesting similar mechanisms may be operative in both species.


Sujet(s)
Endothéline-1/pharmacologie , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Canaux potassiques voltage-dépendants/métabolisme , Artère pulmonaire/effets des médicaments et des substances chimiques , 4-Amino-pyridine/pharmacologie , Adolescent , Adulte , Animaux , Cellules cultivées , Charybdotoxine/pharmacologie , Enfant , Antienzymes/pharmacologie , Femelle , Humains , Techniques in vitro , Indoles/pharmacologie , Mâle , Maléimides/pharmacologie , Adulte d'âge moyen , Muscles lisses vasculaires/cytologie , Muscles lisses vasculaires/métabolisme , Techniques de patch-clamp , Inhibiteurs des canaux potassiques/pharmacologie , Artère pulmonaire/cytologie , Artère pulmonaire/métabolisme , Staurosporine/pharmacologie , Vasoconstriction/effets des médicaments et des substances chimiques , Vasoconstriction/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...